Professional Documents
Culture Documents
Dr Bavi Vythilingum
Division CL Psychiatry, Dept of
Psychiatry UCT
Rondebosch Medical Centre
Psychiatric disorders in pregnancy
Monotherapy
Lowest effective dose
SSRI’s
Risk of teratogenecity
Absolute risk is not clear but appears to be
small
Psychotherapy treatment of choice for
perinatal depression
Weigh risk benefit ratio
Management of Bipolar Disorder
during Pregnancy
Should be by a psychiatrist
Teratogenic risk
– Lithium Ebstein’s anomaly 1-5% (vs 0.5 – 1%
risk)
– Na Valproate NTD, other anomalies, 3x vs other
antiepileptics, 4x general population
– Carbamazepine 1% risk neural tube defects (vs
0.1% risk)
– Lamotrigine limited evidence, cleft palate
Second generation antipsychotics
Attractive
– No described teratogenicity
– Mood stabilisers
Metabolic side effects
– Boden 2012
– gestational diabetes adjusted OR, 1.77 [95% CI,
1.04-3.03]
– Higher risk SGA infant - confounders
Medication Summary
Lithium – safest
Lamotrigine, atypicals – appears safe
Individualise for patient
Adequate risk counselling
Patient falls pregnant on
medication
Mood stabilisers
– All present problems
– Consider risk benefit carefully
Lithium
– Maternal hydration important
Anticonvulsant class
– Rashes
Eglonyl?
Sulpiride
Antipsychotic with theoretical mood elevation
properties at low doses
Side effect of increasing milk supply
Sedating
NOT an effective antidepressant
Pregnancy and lactation summary